Share on LinkedInShare on LinkedIn

ARTICLE · 31 JANUARY 2008

EU Commission Opens Sector Inquiry Into The Pharmaceutical Industry

On 15 January 2008, the European Commission initiated an inquiry into the pharmaceutical sector in relation to the launch of innovative and generic drugs.

European UnionInternational Law
Lesley Ainsworth
Lesley Ainsworth
Christian Bahr
Christian Bahr
Marc Dalby
Marc Dalby
Christopher Thomas
Christopher Thomas

On 15 January 2008, the European Commission initiated an inquiry into the pharmaceutical sector in relation to the launch of innovative and generic drugs.  The Commission's main objective in this investigation is to scrutinise business practices such as (i) obtaining or enforcing patents in a way that does not serve the protection of innovation but restricts competition for innovative drugs and/or generics, (ii) vexatious litigation and (iii) settlement agreements.  This is thus the first EC investigation into settlement agreements in the pharmaceutical sector, following on from the considerable controversy on this issue in the United States.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from